Redhill Biopharma
RDHL
#11130
Rank
S$4.31 M
Marketcap
S$0.49
Share price
0.79%
Change (1 day)
-65.15%
Change (1 year)

Market capitalization of Redhill Biopharma (RDHL)

Market cap: S$4.31 Million

As of November 2026 Redhill Biopharma has a market cap of S$4.31 Million. This makes Redhill Biopharma the world's 11130th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Redhill Biopharma from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026S$4.31 M-42.08%
2025S$7.45 M-38.03%
2024S$12.02 M-68.3%
2023S$37.93 M121.15%
2022S$17.15 M-90.61%
2021S$0.18 B-54.64%
2020S$0.40 B39.6%
2019S$0.28 B34.19%
2018S$0.21 B47.08%
2017S$0.14 B-43.37%
2016S$0.25 B11.51%
2015S$0.23 B49.61%
2014S$0.15 B60.78%
2013S$96.27 M

End of Day market cap according to different sources

On Nov 10th, 2026 the market cap of Redhill Biopharma was reported to be:

S$4.28 Million
by Nasdaq info icon info icon
S$4.28 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
S$148.70 B 3,444,815.10%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$464.11 B 10,751,224.31%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$130.13 B 3,014,470.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$64.45 B 1,493,015.89%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
S$2.07 B 47,972.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel